Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Prepaid Assets (2020 - 2025)

Historic Prepaid Assets for Relay Therapeutics (RLAY) over the last 6 years, with Q3 2025 value amounting to $23.8 million.

  • Relay Therapeutics' Prepaid Assets rose 2731.11% to $23.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.8 million, marking a year-over-year increase of 2731.11%. This contributed to the annual value of $17.3 million for FY2024, which is 386.78% up from last year.
  • As of Q3 2025, Relay Therapeutics' Prepaid Assets stood at $23.8 million, which was up 2731.11% from $16.0 million recorded in Q2 2025.
  • Relay Therapeutics' 5-year Prepaid Assets high stood at $23.8 million for Q3 2025, and its period low was $5.6 million during Q2 2021.
  • Its 5-year average for Prepaid Assets is $14.3 million, with a median of $13.2 million in 2024.
  • Its Prepaid Assets has fluctuated over the past 5 years, first soared by 12834.89% in 2022, then plummeted by 2701.75% in 2023.
  • Relay Therapeutics' Prepaid Assets (Quarter) stood at $11.5 million in 2021, then grew by 5.63% to $12.1 million in 2022, then soared by 37.92% to $16.7 million in 2023, then increased by 3.87% to $17.3 million in 2024, then surged by 37.42% to $23.8 million in 2025.
  • Its last three reported values are $23.8 million in Q3 2025, $16.0 million for Q2 2025, and $22.0 million during Q1 2025.